AI, big data and deep real-world evidence – the challenges and opportunities

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations and is accelerating the development of new and innovative therapies and treatments to improve patient outcomes.

An important source of RWE has, until recently, been locked in the electronic health record (EHR). Now, artificial intelligence (AI) techniques such as natural language processing (NLP) and machine learning are helping clinicians unlock the data from this valuable, unstructured (free-text) information.

This pharmaphorum webinar, held in association with Savana, will take place on Thursday 22 April from 16:00-17:00 BST / 17:00-18:00 CET / 10:00-11:00 EST and hear from presenters at BREATHE - the Health Data Research Hub for Respiratory Health, Salford Royal NHS Foundation Trust and Savana. They will describe how the research ecosystem is embracing AI, Big Data and Deep RWE and addressing its challenges and opportunities.

It will explore the rise of RWE and discuss how unlocking the information in the EHR and development of exciting new health data partnerships and collaboration are changing the way the NHS, researchers and industry can quickly, efficiently and safely access and analyse high quality health data sets.

Focus

The webinar will also cover:

• The challenges of RWE research and how they are being overcome
• Unlocking the clinical value of the EHR with AI and Big Data whilst ensuring the safety of patient data at all times
• The research ecosystem and opportunities for RWE researchers created by the Savana: BREATHE partnership
• Deep RWE in practice - early results from the BigCOVIData study

View the webinar* by clicking on the link in the window above or by clicking here.

Dr Ignacio H Medrano, CMO and founder, Savana is a consultant neurologist with training in healthcare management and experience in clinical research strategies - formerly responsible for +500 researchers. A Singularity University graduate, he is also a founder at Mendelian in the UK which is utilising AI in the diagnosis of rare diseases. Ignacio is in demand as an international speaker at digital health, clinical research, science and technology events and congresses.

Professor Jenni Quint, deputy director, BREATHE – the Health Data Research Hub for Respiratory Health, is currently a Professor of Respiratory Epidemiology at the National Heart and Lung Institute (NHLI), Imperial College London and an Honorary Consultant. She currently also leads a clinical epidemiology research group, partners with the Royal College of Physicians and is Analysis Lead for the National Asthma and COPD Audit Programme.

Professor Nawar Bakerly MD, FRCP is a consultant respiratory physician at Salford Royal NHS Foundation Trust and visiting professor at Manchester Metropolitan University. He is also clinical director for the Department of Respiratory Medicine (Pulmonology) and Chief Clinical Information Officer (CCIO) for Salford Care Organisation - as well as being its lead for integrated COPD services. He has collaborated as lead investigator or co-investigator in clinical trials, including the Salford Lung Studies for asthma and COPD, and also works on various clinical advisory groups for NICE and the NIHR in the UK.

Dominic Tyer, interim managing editor, pharmaphorum [moderator] Dominic Tyer is a trained journalist and editor with over 20 years of pharmaceutical and healthcare publishing experience. He serves as interim managing editor at pharmaphorum media, which facilitates productive engagement for pharma, bringing healthcare together to drive medical innovation. He is also creative and editorial director at the company’s specialist healthcare content consultancy, pharmaphorum connect.